LumiraDX Ltd. is a point of care diagnostics company, which engages in the provision of a diagnostic platform that supports tests with lab-comparable performance at the point of care. The company was founded by Ronald Zwanziger, David Scott, and Jerry McAleer in 2014 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of LumiraDx Limited?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. LumiraDx Limited market cap is $3.62M.
What is the 52-week high for LumiraDx Limited?
52 week high is the highest price of a stock in the past 52 weeks, or one year. LumiraDx Limited 52 week high is $0.3059 as of October 09, 2025.
What is the 52-week low for LumiraDx Limited?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. LumiraDx Limited 52 week low is $0.00 as of October 09, 2025.
What is LumiraDx Limited stock price today?
LumiraDx Limited stock price today is $0.01.
What was LumiraDx Limited stock price yesterday?
LumiraDx Limited stock price yesterday was $0.001.
What is the 50-day moving average of LumiraDx Limited?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. LumiraDx Limited 50-day moving average is $0.0029.